Dr. Ashraf R. Aziz
Claim this profileKaiser Permanente-Baldwin Park
Studies Multiple Myeloma
Studies Lymphoma
11 reported clinical trials
31 drugs studied
Area of expertise
1Multiple Myeloma
2Lymphoma
Stage III
Stage IV
MYC positive
Affiliated Hospitals
Clinical Trials Ashraf R. Aziz is currently running
Mezigdomide + Carfilzomib + Dexamethasone
for Multiple Myeloma
This trial is testing a new drug called Mezigdomide combined with two other drugs to treat patients whose blood cancer has come back or not responded to previous treatments. The new drug aims to stop cancer cells from growing and spreading.
Recruiting2 awards Phase 3
Venetoclax + Obinutuzumab
for Leukemia
This phase III trial compares early treatment with venetoclax and obinutuzumab versus delayed treatment with venetoclax and obinutuzumab in patients with newly diagnosed high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Immunotherapy with monoclonal antibodies, such as obinutuzumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with the venetoclax and obinutuzumab early (before patients have symptoms) may have better outcomes for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma compared to starting treatment with the venetoclax and obinutuzumab after patients show symptoms.
Recruiting2 awards Phase 31 criteria
More about Ashraf R. Aziz
Clinical Trial Related6 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Ashraf R. Aziz has experience with
- Obinutuzumab
- Lenalidomide
- Cyclophosphamide
- Doxorubicin Hydrochloride
- Vincristine Sulfate
- Prednisone
Breakdown of trials Ashraf R. Aziz has run
Multiple Myeloma
Lymphoma
Follicular Lymphoma
Non-Hodgkin's Lymphoma
Chronic Lymphocytic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ashraf R. Aziz specialize in?
Ashraf R. Aziz focuses on Multiple Myeloma and Lymphoma. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is Ashraf R. Aziz currently recruiting for clinical trials?
Yes, Ashraf R. Aziz is currently recruiting for 2 clinical trials in Baldwin Park California. If you're interested in participating, you should apply.
Are there any treatments that Ashraf R. Aziz has studied deeply?
Yes, Ashraf R. Aziz has studied treatments such as Obinutuzumab, Lenalidomide, Cyclophosphamide.
What is the best way to schedule an appointment with Ashraf R. Aziz?
Apply for one of the trials that Ashraf R. Aziz is conducting.
What is the office address of Ashraf R. Aziz?
The office of Ashraf R. Aziz is located at: Kaiser Permanente-Baldwin Park, Baldwin Park, California 91706 United States. This is the address for their practice at the Kaiser Permanente-Baldwin Park.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.